Cholesterol ester transfer protein (CETP) Taq1B polymorphism influences the effect of a standardized cardiac rehabilitation program on lipid risk markers

Atherosclerosis

Volumn 181, Issue 2, 2005, Pages 363-369

  Ayyobi, Amir F ^a,b   Hill, John S ^b   Molhuizen, Henri O F ^d   Lear, Scott A ^b,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c SIMON FRASER UNIVERSITY   (Canada)

^d UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

Author keywords

Cardiac rehabilitation; CETP; Gene environment interactions; Lipoprotein metabolism

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL ESTER TRANSFER PROTEIN; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TAQ POLYMERASE; TRIACYLGLYCEROL LIPASE;

ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; EXERCISE; GENOTYPE; HEART REHABILITATION; HOMOZYGOSITY; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; WEIGHT REDUCTION;

APOLIPOPROTEINS E; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CORONARY ARTERIOSCLEROSIS; FEMALE; GENE FREQUENCY; GENOTYPE; GLYCOPROTEINS; HUMANS; LIPASE; MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 22544434964     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.01.020     Document Type: Article

References (31)

1. G.T. O'Connor, J.E. Buring, and S. Yusuf An overview of randomized trials of rehabilitation with exercise after myocardial infarction Circulation 80 1989 234 244
2. N.B. Oldridge, G.H. Guyatt, M.E. Fischer, and A.A. Rimm Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials J Am Med Assoc 260 1988 945 950
3. P.D. Wood, M.L. Stefanick, and D.M. Dreon Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise N Engl J Med 319 1988 1173 1179
4. G. Schuler, R. Hambrecht, and G. Schlierf Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease Circulation 86 1992 1 11
5. L.I. Katzel, P.J. Coon, J. Dengel, and A.P. Goldberg Effects of an American Heart Association step I diet and weight loss on lipoprotein lipid levels in obese men with silent myocardial ischemia and reduced high-density lipoprotein cholesterol Metabolism 44 1995 307 314
6. B. Eliasson, A. Hjalmarson, E. Kruse, B. Landfeldt, and A. Westin Effect of smoking reduction and cessation on cardiovascular risk factors Nicotine Tob Res 3 2001 249 255
7. J.A. Kuivenhoven, P. de Knijff, and J.M. Boer Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels Arterioscler Thromb Vasc Biol 17 1997 560 568
8. S.S. Deeb, A. Zambon, M.C. Carr, A.F. Ayyobi, and J.D. Brunzell Hepatic lipase and dyslipidemia: interactions between genetic variants, obesity, gender and diet J Lipid Res 16 2003 16
9. J.E. Eichner, S.T. Dunn, and G. Perveen Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review Am J Epidemiol 155 2002 487 495
10. J.M. Ordovas, L.A. Cupples, and D. Corella Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study Arterioscler Thromb Vasc Biol 20 2000 1323 1329
11. K.R. Wilund, R.E. Ferrell, D.A. Phares, A.P. Goldberg, and J.M. Hagberg Changes in high-density lipoprotein-cholesterol subfractions with exercise training may be dependent on cholesteryl ester transfer protein (CETP) genotype Metabolism 51 2002 774 778
12. J.A. Kuivenhoven, J.W. Jukema, and A.H. Zwinderman The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group N Engl J Med 338 1998 86 93
13. J.C. Cohen, Z. Wang, S.M. Grundy, M.R. Stoesz, and R. Guerra Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels J Clin Invest 94 1994 2377 2384
14. R. Guerra, J. Wang, S.M. Grundy, and J.C. Cohen A hepatic lipase (LIPC) allele associated with high plasma concentrations of high-density lipoprotein cholesterol Proc Natl Acad Sci USA 94 1997 4532 4537
15. S.M. Grundy, G.L. Vega, J.D. Otvos, D.L. Rainwater, and J.C. Cohen Hepatic lipase activity influences high-density lipoprotein subclass distribution in normotriglyceridemic men. Genetic and pharmacological evidence J Lipid Res 40 1999 229 234
16. J.H. Auwerx, C.A. Marzetta, J.E. Hokanson, and J.D. Brunzell Large buoyant LDL-like particles in hepatic lipase deficiency Arteriosclerosis 9 1989 319 325
17. R.J. Deckelbaum, R. Ramakrishnan, S. Eisenberg, T. Olivecrona, and G. Bengtsson-Olivecrona Triacylglycerol and phospholipid hydrolysis in human plasma lipoproteins: role of lipoprotein and hepatic lipase Biochemistry 31 1992 8544 8551
18. A. Zambon, S.S. Deeb, B.G. Brown, J.E. Hokanson, and J.D. Brunzell Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment Circulation 103 2001 792 798
19. C.F. Sing, and J. Davignon Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation Am J Hum Genet 37 1985 268 285
20. G. Utermann Apolipoprotein E polymorphism in health and disease Am Heart J 113 1987 433 440
21. M.J. Tikkanen, J.K. Huttunen, C. Ehnholm, and P. Pietinen Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet Arteriosclerosis 10 1990 285 288
22. J. Lopez-Miranda, J.M. Ordovas, and P. Mata Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol J Lipid Res 35 1994 1965 1975
23. Anonymous National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II) Circulation 89 1994 1333 1445
24. A. Zambon, S.S. Deeb, J.E. Hokanson, B.G. Brown, and J.D. Brunzell Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol Arterioscler Thromb Vasc Biol 18 1998 1723 1729
25. M.E. Brousseau, J.J. O'Connor Jr, and J.M. Ordovas Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial Arterioscler Thromb Vasc Biol 22 2002 1148 1154
26. M.C. Carr, A.F. Ayyobi, S.J. Murdoch, S.S. Deeb, and J.D. Brunzell Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women Arterioscler Thromb Vasc Biol 22 2002 667 673
27. G.G. Blackburn, J.M. Foody, and D.L. Sprecher Cardiac rehabilitation participation patterns in a large, tertiary care center: evidence for selection bias J Cardiopulm Rehabil 20 2000 189 195
28. K.M. King, and K.K. Teo Cardiac rehabilitation referral and attendance: not one and the same Rehabil Nurs 23 1998 246 251
29. K.M. King, D.P. Humen, and K.K. Teo Cardiac rehabilitation: the forgotten intervention Can J Cardiol 15 1999 979 985
30. K.R. Evenson, W.D. Rosamond, and R.V. Luepker Predictors of outpatient cardiac rehabilitation utilization: the Minnesota Heart Surgery Registry J Cardiopulm Rehabil 18 1998 192 198
31. Bittner V, Sanderson B, Breland J, Green D. Referral patterns to a University-based cardiac rehabilitation program. Am J Cardiol 1999;83:252-5, A5.